Market Closed -
Bombay S.E.
06:00:54 2024-05-09 EDT
|
5-day change
|
1st Jan Change
|
740.2
INR
|
-6.27%
|
|
-13.39%
|
-10.80%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
2,085
|
1,189
|
498.5
|
1,428
|
4,552
|
4,189
|
Enterprise Value (EV)
1 |
3,159
|
2,228
|
1,581
|
2,276
|
5,292
|
4,959
|
P/E ratio
|
173
x
|
539
x
|
77.5
x
|
10.1
x
|
16.6
x
|
30.7
x
|
Yield
|
-
|
-
|
-
|
-
|
0.32%
|
0.35%
|
Capitalization / Revenue
|
1.14
x
|
0.63
x
|
0.28
x
|
0.72
x
|
1.87
x
|
1.71
x
|
EV / Revenue
|
1.72
x
|
1.17
x
|
0.87
x
|
1.15
x
|
2.17
x
|
2.03
x
|
EV / EBITDA
|
19.9
x
|
13.5
x
|
9.26
x
|
7.46
x
|
16.9
x
|
15.6
x
|
EV / FCF
|
-25.7
x
|
25.6
x
|
-38.4
x
|
11.8
x
|
-69.7
x
|
-82.4
x
|
FCF Yield
|
-3.89%
|
3.91%
|
-2.61%
|
8.49%
|
-1.44%
|
-1.21%
|
Price to Book
|
18.8
x
|
10.6
x
|
4.22
x
|
5.46
x
|
8.48
x
|
6.35
x
|
Nbr of stocks (in thousands)
|
7,353
|
7,353
|
7,353
|
7,353
|
7,353
|
7,353
|
Reference price
2 |
283.5
|
161.8
|
67.80
|
194.2
|
619.0
|
569.6
|
Announcement Date
|
18-08-31
|
19-08-22
|
20-08-25
|
21-08-25
|
22-07-05
|
23-07-31
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,835
|
1,897
|
1,811
|
1,987
|
2,440
|
2,448
|
EBITDA
1 |
158.6
|
164.5
|
170.8
|
305
|
312.4
|
318.3
|
EBIT
1 |
98.9
|
105.9
|
109.9
|
247
|
254.3
|
253.8
|
Operating Margin
|
5.39%
|
5.58%
|
6.07%
|
12.43%
|
10.42%
|
10.37%
|
Earnings before Tax (EBT)
1 |
15.13
|
2.226
|
11.94
|
166.2
|
391.8
|
190.8
|
Net income
1 |
12.05
|
2.226
|
6.436
|
141.8
|
274.8
|
136.6
|
Net margin
|
0.66%
|
0.12%
|
0.36%
|
7.14%
|
11.26%
|
5.58%
|
EPS
2 |
1.639
|
0.3000
|
0.8753
|
19.29
|
37.37
|
18.58
|
Free Cash Flow
1 |
-122.8
|
87.02
|
-41.24
|
193.1
|
-75.98
|
-60.18
|
FCF margin
|
-6.69%
|
4.59%
|
-2.28%
|
9.72%
|
-3.11%
|
-2.46%
|
FCF Conversion (EBITDA)
|
-
|
52.89%
|
-
|
63.33%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
3,909.16%
|
-
|
136.17%
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
2.000
|
2.000
|
Announcement Date
|
18-08-31
|
19-08-22
|
20-08-25
|
21-08-25
|
22-07-05
|
23-07-31
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
1,075
|
1,039
|
1,083
|
848
|
741
|
771
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
6.777
x
|
6.314
x
|
6.341
x
|
2.781
x
|
2.371
x
|
2.421
x
|
Free Cash Flow
1 |
-123
|
87
|
-41.2
|
193
|
-76
|
-60.2
|
ROE (net income / shareholders' equity)
|
11.5%
|
1.99%
|
5.57%
|
74.7%
|
68.8%
|
22.8%
|
ROA (Net income/ Total Assets)
|
4.15%
|
4.35%
|
4.66%
|
10.8%
|
10.2%
|
9.05%
|
Assets
1 |
290.1
|
51.22
|
138.1
|
1,309
|
2,693
|
1,510
|
Book Value Per Share
2 |
15.10
|
15.30
|
16.10
|
35.60
|
73.00
|
89.80
|
Cash Flow per Share
2 |
3.580
|
2.540
|
1.430
|
4.040
|
6.070
|
0.0900
|
Capex
1 |
39.3
|
21
|
67.5
|
38.4
|
163
|
82.1
|
Capex / Sales
|
2.14%
|
1.11%
|
3.73%
|
1.93%
|
6.7%
|
3.35%
|
Announcement Date
|
18-08-31
|
19-08-22
|
20-08-25
|
21-08-25
|
22-07-05
|
23-07-31
|
|
1st Jan change
|
Capi.
|
---|
| -10.80% | 69.57M | | +17.76% | 66.6B | | +0.84% | 48.75B | | +17.11% | 41.45B | | +19.92% | 26.74B | | +11.45% | 19.55B | | +3.89% | 18.21B | | -21.31% | 16.02B | | +3.82% | 15.62B | | -7.57% | 15.33B |
Other Specialty Chemicals
|